Beta-Amyloid Imaging With [18F]NAV4694 Positron Emission Tomography (PET) in Predicting Progression to Alzheimer's Disease (AD) in Subjects With Mild Cognitive Impairment (MCI) (NAV4-04)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01812213

Recruitment Status : Unknown

Verified July 2017 by Navidea Biopharmaceuticals.
Recruitment status was: Active, not recruiting

First Posted : March 18, 2013

Last Update Posted : July 26, 2017

Sponsor:

Information provided by (Responsible Party):

Navidea Biopharmaceuticals

Study Details
Tabular View
No Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Unknown
Estimated Primary Completion Date :	June 2018
Estimated Study Completion Date :	August 2018

To Top